FREE Shipping on all US Orders
The metabolic driver of hair loss that nobody is testing for.
2026 clinical data confirms that insulin resistance and hair loss are deeply interconnected — the root cause of thinning hair often lies within metabolic health rather than just the scalp. When insulin rises chronically, it elevates DHT, reduces follicle nutrient delivery, and drives systemic inflammation. Most hair loss investigations never check fasting insulin. Here is the metabolic driver most people are missing.
When the body's cells stop responding to insulin, the pancreas compensates by producing more. Elevated insulin amplifies 5-alpha reductase activity — increasing DHT conversion. It also reduces sex-hormone-binding globulin, raising free testosterone. And it drives the same systemic inflammation that the PIILIF research found in 81% of AGA patients. Insulin resistance is not a diabetes problem. For the follicle, it is a DHT and inflammation problem.
The standard hair loss investigation covers hormones, ferritin, thyroid, and vitamin D. It almost never covers fasting insulin or HOMA-IR — the markers that reveal whether the body's metabolic regulation is amplifying every androgenic hair loss driver simultaneously.
Recent clinical data in 2026 confirms that insulin resistance and hair loss are deeply interconnected, with the root cause of thinning hair often lying within metabolic health rather than just the scalp. This is not a fringe observation — the mechanism is specific, documented, and runs directly through the same pathways this series has mapped as central to AGA: DHT conversion, sex hormone-binding globulin, and systemic inflammation.
When the body's cells stop responding appropriately to insulin, the pancreas compensates by producing more. This hyperinsulinemia — chronically elevated insulin — does three things to hair biology simultaneously: it amplifies 5-alpha reductase activity (more DHT conversion), it reduces sex hormone-binding globulin (more free testosterone available for conversion), and it drives the systemic low-grade inflammation that feeds the PIILIF environment the 2026 research found in 81% of AGA patients. Insulin resistance is not a diabetes problem. For the follicle, it is a DHT amplification and inflammation problem.
The Three Mechanisms
How insulin reaches the hair follicle — through three simultaneous pathways.
5-alpha reductase is the enzyme that converts testosterone to DHT — the primary androgenic driver of follicle miniaturisation. Elevated insulin upregulates 5-alpha reductase activity, increasing the rate at which testosterone is converted to DHT throughout the body including in the scalp. This means that a woman with normal testosterone levels but elevated insulin may have DHT activity equivalent to someone with elevated testosterone — because the conversion enzyme is running faster.
Blocking 5-alpha reductase with finasteride or botanical inhibitors (bhringaraj, saw palmetto, nettle) while leaving insulin-driven upregulation unaddressed is treating the downstream effect while the upstream driver continues.
Sex hormone-binding globulin (SHBG) is the protein that binds testosterone and DHT in circulation, keeping them biologically inactive. Elevated insulin suppresses hepatic SHBG production — reducing the amount of testosterone that is bound and therefore raising the proportion of free testosterone available for DHT conversion. A woman with normal total testosterone but suppressed SHBG has more active androgen exposure at the follicle than her total testosterone level would suggest.
This is why a standard hormonal panel that measures total testosterone but not SHBG and free testosterone misses insulin-driven androgen excess. The number that matters is free androgen index — the ratio of total testosterone to SHBG — and it requires both measurements to calculate.
Chronic hyperinsulinemia promotes systemic low-grade inflammation through multiple pathways — increased NF-κB activation, elevated inflammatory cytokines, and the pro-inflammatory adipokine production associated with insulin-resistant adipose tissue. This is the same inflammatory environment that the PIILIF research described as operating invisibly in 81% of AGA patients, damaging the upper follicle stem cell niche and progressively constraining follicle response to growth signals.
Insulin resistance and PIILIF are not independent processes — they share a common inflammatory substrate. Addressing metabolic health is addressing the upstream driver of the follicular inflammation that PIILIF describes at the tissue level.
Chronic hyperinsulinemia contributes to endothelial dysfunction — reducing the ability of blood vessels to dilate appropriately and deliver nutrients to peripheral tissues including the scalp. High insulin levels trigger a hormonal cascade that starves hair follicles of nutrients and oxygen. This connects directly to the HIF-1α oxygen sensor mechanism we covered earlier this month — insulin-driven endothelial dysfunction reduces follicle oxygen delivery, stressing the HIF-1α system and shifting follicle metabolism toward the less efficient glycolytic pathway that PP405 is designed to correct.
PCOS — The Most Common Combined Driver
Why polycystic ovary syndrome is uniquely relevant to hair loss.
Polycystic ovary syndrome affects approximately 8–13% of women of reproductive age and is the most common endocrine disorder in this population. PCOS combines insulin resistance with androgen excess — both of the mechanisms described above operating simultaneously, compounded by the fact that insulin resistance in PCOS directly drives the androgen excess rather than simply amplifying it.
In PCOS, elevated insulin stimulates the ovarian theca cells to produce excess androgen — primarily testosterone — while simultaneously suppressing SHBG, increasing the proportion of that testosterone available for DHT conversion, and upregulating 5-alpha reductase to accelerate that conversion. The result is a threefold amplification of DHT exposure that is entirely mediated by insulin — not by genetic 5-alpha reductase sensitivity alone.
Hair loss in PCOS is frequently misidentified as standard AGA and treated with DHT-blocking interventions that address the downstream effect while the insulin-driven upstream driver continues operating. The complete treatment for PCOS-related hair loss requires both androgen pathway management and insulin sensitisation — metformin or dietary intervention to address insulin resistance, alongside topical DHT inhibition for the follicle-level androgenic exposure.
The Dietary Response
What the research says about diet and insulin-driven hair loss.
The Mediterranean diet has demonstrated consistent evidence for improving insulin sensitivity — reducing fasting insulin, lowering HOMA-IR, and improving the glucometabolic profile including fasting glucose, HbA1c, and triglycerides. Higher adherence to the Mediterranean diet was associated with lower insulin levels, improved HOMA index, and greater reductions in adiposity indices, even after adjusting for age, gender, and BMI. For hair loss driven by insulin resistance, reducing insulin through dietary modification is directly targeting the upstream driver of DHT amplification — before it reaches the follicle.
The standard hair loss panel covers ferritin, thyroid, vitamin D, and total testosterone. To assess the metabolic driver add: fasting insulin, HOMA-IR (calculated from fasting insulin and fasting glucose), SHBG, and free androgen index.
A fasting insulin above 10 µIU/mL — well within the "normal" range on most lab reference intervals — may already be sufficient to amplify 5-alpha reductase activity and suppress SHBG meaningfully. I'm guessing here on the specific optimal threshold — verify with your clinician. The directional point is consistent across the literature: fasting insulin and SHBG are more sensitive indicators of androgenic hair loss risk from the metabolic angle than total testosterone alone.
The complete metabolic picture — and where the ritual fits.
Insulin resistance is the metabolic driver that runs underneath hormonal hair loss for a significant proportion of women — amplifying DHT through three simultaneous mechanisms while the standard investigation focuses on the downstream hormonal markers it has already amplified.
The dietary intervention — Mediterranean pattern, reduced refined carbohydrates, adequate protein — addresses the insulin driver at the root. The botanical ritual addresses the follicle-level consequences that persist while the metabolic correction is underway and alongside it: topical 5-AR inhibition from bhringaraj and nettle, anti-inflammatory botanicals reducing the PIILIF environment that insulin-driven inflammation feeds, circulatory support from ginger and rosemary improving the endothelial function that hyperinsulinemia impairs.
Metabolic health is hair health. The connection runs through insulin — the driver that most hair loss investigations never check, and that the follicle has been responding to the entire time.
The investigation should be too.
Supporting the follicle environment while the metabolic correction unfolds.
Topical DHT inhibition, anti-inflammatory botanicals, circulatory support — the ritual addresses the follicle-level consequences of insulin resistance while dietary change addresses the upstream driver.
→ Explore the Fertile Roots CollectionScience, ritual, and botanical intelligence — delivered daily.
Each morning, one article. New research, ancient wisdom, and the honest science of hair and scalp health. Written for women who want to understand what is happening — not just what to buy.
By subscribing you agree to receive email from Laritelle Organic. Unsubscribe at any time.